ECO Animal Health Group (LON:EAH) Sets New 1-Year Low – Here’s Why

ECO Animal Health Group plc (LON:EAH)’s stock price reached a new 52-week low during trading on Monday . The company traded as low as GBX 60 ($0.76) and last traded at GBX 66 ($0.84), with a volume of 56562 shares trading hands. The stock had previously closed at GBX 66 ($0.84).

Analyst Upgrades and Downgrades

Separately, Shore Capital reiterated a “buy” rating on shares of ECO Animal Health Group in a research report on Tuesday, August 27th.

ECO Animal Health Group Trading Down 2.2 %

The company has a current ratio of 2.96, a quick ratio of 2.14 and a debt-to-equity ratio of 4.31. The company has a market cap of £43.39 million, a price-to-earnings ratio of 3,275.00 and a beta of -0.05. The business’s 50 day moving average price is GBX 80.77 and its 200-day moving average price is GBX 104.27.

Insider Activity at ECO Animal Health Group

In related news, insider David Hallas bought 18,181 shares of the company’s stock in a transaction that occurred on Friday, August 30th. The shares were bought at an average price of GBX 110 ($1.40) per share, for a total transaction of £19,999.10 ($25,379.57). 21.65% of the stock is currently owned by insiders.

ECO Animal Health Group Company Profile

ECO Animal Health Group plc, together with its subsidiaries, develops, registers, and markets pharmaceutical products for animals worldwide. The company provides Aivlosin, a macrolide antibiotic for the treatment of enteric and respiratory diseases in pigs and poultry. It also offers generic drugs, such as Ecomectin, Ecoheart, Ecotraz, and Ecomintic, which are endectocides and other antiparasitics for the treatment and prevention of parasites, such as worms, ticks, mange, and lices in cattle, sheep, pigs, horses, and dogs; and Chlortetracycline and Oxytetracycline for treatment of bacterial infections in pigs, poultry, and cattle.